Results 21 to 30 of about 48,868 (199)

Knowledge, attitude and practice of pharmacovigilance among Nepalese health professionals

open access: yes, 2022
Introduction: Although Nepal joined the WHO program for International Drug Monitoring in 2006, published data about Nepalese health professionals’ understanding of pharmacovigilance and spontaneous reporting of adverse drug reactions (ADRs) is limited ...
White, K.   +6 more
core   +1 more source

Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan

open access: yesInfectious Diseases and Therapy, 2023
Introduction Molnupiravir is an oral antiviral drug that received special approval for emergency use in Japan on December 24 2021 for infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Masahiro Kimata   +4 more
doaj   +1 more source

Suvorexant (Belsomra® Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey

open access: yesDrugs in R&D, 2018
Background We report on the results of a Japanese postmarketing drug-use survey of suvorexant (Belsomra®) tablets. Methods A survey with a ≤ 6-month observation period after the start of administration was conducted, targeting insomnia patients who were ...
Yuko Asai   +5 more
doaj   +1 more source

Identification of International Society on Thrombosis and Haemostasis major and clinically relevant non-major bleed events from electronic health records: a novel algorithm to enhance data utilisation from real-world sources

open access: yesInternational Journal of Population Data Science, 2023
Introduction In randomised controlled trials (RCTs), bleeding outcomes are often assessed using definitions provided by the International Society on Thrombosis and Haemostasis (ISTH).
Alexander Hartenstein   +5 more
doaj   +1 more source

From sentinel surveillance for sleeping sickness treatment failure to the development of a pharmacovigilance approach [PDF]

open access: yes, 2011
In the late 1990’s a disturbing trend of geographically distinct melarsoprol treatment failures accompanied a dramatic resurgence of Human African Trypanosomiasis.
Dahl, Benjamin Arthur
core   +1 more source

Current career situations of Chinese pharmacovigilance professionals working for pharmaceutical companies: an exploratory survey

open access: yesBMC Health Services Research, 2023
Background Pharmacovigilance in China has experienced rapid development in the past 30 years. The implementation of Good Pharmacovigilance Practice in China since the end of 2021 heralds a new era of pharmacovigilance affairs, which puts forward higher ...
Yalan Tang   +4 more
doaj   +1 more source

Audits and inspections of pharmacovigilance systems in Russia

open access: yesКачественная клиническая практика, 2023
The implementation of pharmacovigilance activities is impossible in isolation from compliance with the quality requirements of medicines and the activities of pharmaceutical and medical organizations throughout the pharmaceutical practice, as well as ...
A. A. Taube, B. K. Romanov
doaj   +1 more source

Pharmacovigilance in oncology [PDF]

open access: yesInternational Journal of Clinical Pharmacy, 2018
AbstractBackground Side effects of cancer therapy are one of the most important issues faced by cancer patients during their illness. Pharmacovigilance, namely the science and activities aimed at monitoring the safety of drugs, is particularly important in oncology, due to the intrinsic biologic toxicity of antineoplastic agents, their narrow ...
Paolo Baldo   +4 more
openaire   +2 more sources

Pharmacovigilance of antimalarial treatment in Africa: is it possible? [PDF]

open access: yes, 2006
Pharmacovigilance, defined as "the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug related problem", is increasingly being recognized in Africa.
Talisuna, Ambrose O   +11 more
core   +1 more source

The Case of Catalan Regional Activities that Propelled the Spanish Pharmacovigilance System

open access: yes, 2023
The Spanish System of Pharmacovigilance (SSPV) started its activities almost 40 years ago, in 1985. Of particular interest to others considering various options for developing pharmacovigilance systems is ...
Figueras, Albert   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy